These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38795131)

  • 1. Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axis.
    Edin C; Ekstedt M; Karlsson M; Wegmann B; Warntjes M; Swahn E; Östgren CJ; Ebbers T; Lundberg P; Carlhäll CJ
    Eur Radiol; 2024 May; ():. PubMed ID: 38795131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic fat is associated with cardiac remodeling-A comprehensive assessment of regional fat depots in type 2 diabetes using multi-parametric MRI.
    Edin C; Ekstedt M; Scheffel T; Karlsson M; Swahn E; Östgren CJ; Engvall J; Ebbers T; Leinhard OD; Lundberg P; Carlhäll CJ
    Front Cardiovasc Med; 2022; 9():813427. PubMed ID: 35966535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of abdominal adiposity, hepatic shear stiffness with subclinical left-ventricular remodeling evaluated by magnetic resonance in adults free of overt cardiovascular diseases: a prospective study.
    Qu Y; Liu J; Li J; Shen S; Chen X; Tang H; Yuan Y; Xia C; Deng L; Chen G; Zheng T; Chen J; Nie L; Yuan F; Tong N; Peng L; Song B
    Cardiovasc Diabetol; 2023 Apr; 22(1):99. PubMed ID: 37120545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the Non-Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross-sectional study in China.
    Fan N; Ding X; Zhen Q; Gu L; Zhang A; Shen T; Wang Y; Peng Y
    J Diabetes Investig; 2021 Jun; 12(6):1035-1041. PubMed ID: 33030804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation.
    Zhao L; Li S; Zhang C; Tian J; Lu A; Bai R; An J; Greiser A; Huang J; Ma X
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):30. PubMed ID: 33745456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.
    Parvanescu T; Vitel A; Sporea I; Mare R; Buz B; Bordejevic DA; Tomescu MC; Arnautu SF; Morariu VI; Citu IM
    Diabetes Metab Syndr Obes; 2021; 14():1535-1545. PubMed ID: 33859484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac remodelling in non-alcoholic fatty liver disease in the general population.
    Kostka F; Ittermann T; Groß S; Laqua FC; Bülow R; Völzke H; Dörr M; Kühn JP; Markus MRP; Kromrey ML
    Liver Int; 2024 Apr; 44(4):1032-1041. PubMed ID: 38293745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant Association between Subclinical Left Cardiac Dysfunction and Liver Stiffness in Metabolic Syndrome Patients with Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease.
    Apostu A; Malita D; Arnautu SF; Tomescu MC; Gaiță D; Popescu A; Mare R; Gidea R; Arnautu DA
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837528
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease.
    Ahn JH; Yu JS; Park KS; Kang SH; Huh JH; Chang JS; Lee JH; Kim MY; Nickel MD; Kannengiesser S; Kim JY; Koh SB
    Magn Reson Imaging; 2021 Jul; 80():1-8. PubMed ID: 33798658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.
    Ajmera V; Cepin S; Tesfai K; Hofflich H; Cadman K; Lopez S; Madamba E; Bettencourt R; Richards L; Behling C; Sirlin CB; Loomba R
    J Hepatol; 2023 Mar; 78(3):471-478. PubMed ID: 36410554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Structure and Function in Patients With Obesity and Non-alcoholic Fatty Liver Disease.
    Asatullina Z; Sineglazova AV
    Cureus; 2023 Aug; 15(8):e43711. PubMed ID: 37724205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial.
    Attaran F; Emami S; Sohrabi M; Malek M; Ajdarkosh H; Khoonsari M; Ismail-Beigi F; Khamseh ME
    BMC Gastroenterol; 2023 Sep; 23(1):327. PubMed ID: 37742004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease.
    Sonaglioni A; Cerini F; Cerrone A; Argiento L; Nicolosi GL; Rigamonti E; Lombardo M; Rumi MG; Viganò M
    Intern Emerg Med; 2022 Aug; 17(5):1425-1438. PubMed ID: 35302179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis.
    Chen J; Allen AM; Therneau TM; Chen J; Li J; Hoodeshenas S; Chen J; Lu X; Zhu Z; Venkatesh SK; Song B; Ehman RL; Yin M
    Eur Radiol; 2022 Feb; 32(2):950-958. PubMed ID: 34432123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction.
    Chung GE; Lee JH; Lee H; Kim MK; Yim JY; Choi SY; Kim YJ; Yoon JH; Kim D
    Atherosclerosis; 2018 May; 272():137-144. PubMed ID: 29604480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease.
    Park JG; Jung J; Verma KK; Kang MK; Madamba E; Lopez S; Qas Yonan A; Liu A; Bettencourt R; Sirlin C; Loomba R
    Aliment Pharmacol Ther; 2021 May; 53(9):1030-1037. PubMed ID: 33764550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes.
    Denimal D; Béland-Bonenfant S; Pais-de-Barros JP; Rouland A; Bouillet B; Duvillard L; Vergès B; Petit JM
    Cardiovasc Diabetol; 2023 Nov; 22(1):310. PubMed ID: 37940926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late effects of pediatric hematopoietic stem cell transplantation on left ventricular function, aortic stiffness and myocardial tissue characteristics.
    Paiman EHM; Louwerens M; Bresters D; Westenberg JJM; Tao Q; van der Geest RJ; Lankester AC; Roest AAW; Lamb HJ
    J Cardiovasc Magn Reson; 2019 Jan; 21(1):6. PubMed ID: 30651110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.